Site Members can sign up for company wide alerts
Investigation Overview
July 2, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) shares was announced concerning whether the offer to acquire Amylin Pharmaceuticals, Inc. at $31 per NASDAQ:AMLN shares and the takeover process are unfair to investors in NASDAQ:AMLN shares. The investigation by a law firm concerns whether certain officers a...
You must register (for free) or login to view the entire investigation.